Needle MN - Search Results

1

TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinoma.

Albiges L, Barthélémy P, Gross-Goupil M, Negrier S, Needle MN, Escudier B. Albiges L, et al. Among authors: needle mn. Ann Oncol. 2021 Jan;32(1):97-102. doi: 10.1016/j.annonc.2020.09.021. Epub 2020 Sep 30. Ann Oncol. 2021. PMID: 33010459 Free article.

2

Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study.

Rini BI, Pal SK, Escudier BJ, Atkins MB, Hutson TE, Porta C, Verzoni E, Needle MN, McDermott DF. Rini BI, et al. Among authors: needle mn. Lancet Oncol. 2020 Jan;21(1):95-104. doi: 10.1016/S1470-2045(19)30735-1. Epub 2019 Dec 3. Lancet Oncol. 2020. PMID: 31810797 Clinical Trial.

3

Final Overall Survival Results from a Phase 3 Study to Compare Tivozanib to Sorafenib as Third- or Fourth-line Therapy in Subjects with Metastatic Renal Cell Carcinoma.

Pal SK, Escudier BJ, Atkins MB, Hutson TE, Porta C, Verzoni E, Needle MN, Powers D, McDermott DF, Rini BI. Pal SK, et al. Among authors: needle mn. Eur Urol. 2020 Dec;78(6):783-785. doi: 10.1016/j.eururo.2020.08.007. Epub 2020 Sep 13. Eur Urol. 2020. PMID: 32938569 Clinical Trial.

4

Q-TWiST Analysis of Tivozanib Versus Sorafenib in Patients With Advanced Renal Cell Carcinoma in the TIVO-3 Study.

Szarek M, Needle MN, Rini BI, Pal SK, McDermott DF, Atkins MB, Hutson TE, Escudier BJ. Szarek M, et al. Among authors: needle mn. Clin Genitourin Cancer. 2021 Oct;19(5):468.e1-468.e5. doi: 10.1016/j.clgc.2021.03.018. Epub 2021 Apr 3. Clin Genitourin Cancer. 2021. PMID: 33980467 Free article. Clinical Trial.

5

Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer.

Thienelt CD, Bunn PA Jr, Hanna N, Rosenberg A, Needle MN, Long ME, Gustafson DL, Kelly K. Thienelt CD, et al. Among authors: needle mn. J Clin Oncol. 2005 Dec 1;23(34):8786-93. doi: 10.1200/JCO.2005.03.1997. Epub 2005 Oct 24. J Clin Oncol. 2005. PMID: 16246975 Clinical Trial.

6

Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial.

Xiong HQ, Rosenberg A, LoBuglio A, Schmidt W, Wolff RA, Deutsch J, Needle M, Abbruzzese JL. Xiong HQ, et al. J Clin Oncol. 2004 Jul 1;22(13):2610-6. doi: 10.1200/JCO.2004.12.040. J Clin Oncol. 2004. PMID: 15226328 Clinical Trial.

7

Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer.

Robert F, Blumenschein G, Herbst RS, Fossella FV, Tseng J, Saleh MN, Needle M. Robert F, et al. Among authors: needle m. J Clin Oncol. 2005 Dec 20;23(36):9089-96. doi: 10.1200/JCO.2004.00.1438. Epub 2005 Nov 21. J Clin Oncol. 2005. PMID: 16301597 Clinical Trial.

8

A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma.

Posey JA, Ng TC, Yang B, Khazaeli MB, Carpenter MD, Fox F, Needle M, Waksal H, LoBuglio AF. Posey JA, et al. Clin Cancer Res. 2003 Apr;9(4):1323-32. Clin Cancer Res. 2003. PMID: 12684400 Clinical Trial.

9

Phase II trial of antiepidermal growth factor receptor antibody C225 in patients with advanced renal cell carcinoma.

Motzer RJ, Amato R, Todd M, Hwu WJ, Cohen R, Baselga J, Muss H, Cooper M, Yu R, Ginsberg MS, Needle M. Motzer RJ, et al. Invest New Drugs. 2003 Feb;21(1):99-101. doi: 10.1023/a:1022928612511. Invest New Drugs. 2003. PMID: 12795534 Clinical Trial.

10

Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.

Pfister DG, Su YB, Kraus DH, Wolden SL, Lis E, Aliff TB, Zahalsky AJ, Lake S, Needle MN, Shaha AR, Shah JP, Zelefsky MJ. Pfister DG, et al. Among authors: needle mn. J Clin Oncol. 2006 Mar 1;24(7):1072-8. doi: 10.1200/JCO.2004.00.1792. J Clin Oncol. 2006. PMID: 16505426 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters